Co-Authors
This is a "connection" page, showing publications co-authored by Ryan Ungaro and Walter Reinisch.
Connection Strength
1.394
-
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflamm Bowel Dis. 2022 02 01; 28(2):314-317.
Score: 0.994
-
Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021 04; 70(4):725-732.
Score: 0.227
-
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol. 2021 10; 19(10):2210-2213.e3.
Score: 0.059
-
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. J Crohns Colitis. 2021 May 04; 15(5):860-863.
Score: 0.059
-
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 08; 159(2):481-491.e3.
Score: 0.055